Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cipla
US Army
Harvard Business School
UBS
Federal Trade Commission
Baxter
Merck
AstraZeneca

Generated: April 21, 2018

DrugPatentWatch Database Preview

Profile for South Korea Patent: 20060061822

« Back to Dashboard

US Patent Family Members and Approved Drugs for South Korea Patent: 20060061822

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
➤ Try a Free Trial Aug 9, 2024 Lilly HUMALOG KWIKPEN insulin lispro recombinant
➤ Try a Free Trial Aug 9, 2024 Lilly HUMALOG MIX 50/50 KWIKPEN insulin lispro protamine recombinant; insulin lispro recombinant
➤ Try a Free Trial Aug 9, 2024 Lilly HUMALOG MIX 75/25 KWIKPEN insulin lispro protamine recombinant; insulin lispro recombinant
➤ Try a Free Trial Aug 9, 2024 Lilly HUMULIN 70/30 insulin recombinant human; insulin susp isophane recombinant human
US Patent Number US Expiration Date US Applicant US Tradename Generic Name

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Covington
UBS
Cipla
Chubb
Teva
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.